The estimated Net Worth of Michael P Spears is at least 14.3 百万$ dollars as of 9 March 2023. Mr. Spears owns over 1,336 units of Insulet stock worth over 3,185,943$ and over the last 9 years he sold PODD stock worth over 9,533,595$. In addition, he makes 1,543,480$ as Senior Vice President - Regulatory Affairs and Compliance at Insulet.
Michael has made over 18 trades of the Insulet stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 1,336 units of PODD stock worth 99,532$ on 9 March 2023.
The largest trade he's ever made was exercising 22,257 units of Insulet stock on 15 September 2020 worth over 659,475$. On average, Michael trades about 2,586 units every 46 days since 2016. As of 9 March 2023 he still owns at least 13,990 units of Insulet stock.
You can see the complete history of Mr. Spears stock trades at the bottom of the page.
Michael Spears serves as Senior Vice President - Regulatory Affairs and Compliance of the Company. Mr. Spears has served as our Senior Vice President Regulatory Affairs and Compliance since May 2019. From February 2017 to May 2019, Mr. Spears served as our Senior Vice President, Quality and Regulatory Affairs. From July 2015 to February 2017, Mr. Spears served as our Senior Vice President, Quality, Regulatory and Clinical Affairs. From 2011 to July 2015, Mr. Spears served as Vice President, Quality Assurance & Regulatory Affairs at Covidien plc, which was acquired by Medtronic in 2015. From 2006 to 2011, Mr. Spears served as Vice President, Quality Assurance at Covidien. From 1999 to 2006, he had several years of progressively broader assignments at Covidien, then known as Tyco Healthcare. Mr. Spears also served as a paralegal at two law firms over an 11-year period. He earned his Bachelor of Arts from the University of Tennessee and a Master of Business Administration from the University of South Carolina.
As the Senior Vice President - Regulatory Affairs and Compliance of Insulet, the total compensation of Michael Spears at Insulet is 1,543,480$. There are 6 executives at Insulet getting paid more, with Shacey Petrovic having the highest compensation of 5,883,980$.
Michael Spears is 55, he's been the Senior Vice President - Regulatory Affairs and Compliance of Insulet since 2019. There are 10 older and 10 younger executives at Insulet. The oldest executive at Insulet Corporation is John Fallon, 72, who is the Independent Director.
Michael's mailing address filed with the SEC is C/O INSULET CORPORATION, 100 NAGOG PARK, ACTON, MA, 01720.
Over the last 18 years, insiders at Insulet have traded over 64,849,299$ worth of Insulet stock and bought 175,262 units worth 7,280,516$ . The most active insiders traders include Jonathan Silverstein、Elizabeth H Weatherman、Samuel D Colella. On average, Insulet executives and independent directors trade stock every 19 days with the average trade being worth of 2,473,148$. The most recent stock trade was executed by Timothy J Scannell on 10 September 2024, trading 5,000 units of PODD stock currently worth 1,129,200$.
insulet corporation is an innovative medical device company based in billerica, massachusetts. it was founded in 2000 with the mission of improving the lives of people with diabetes. specifically, through its revolutionary omnipod insulin management system, insulet seeks to expand the use of insulin pump therapy. studies have demonstrated the advantages of insulin pump therapy over multiple daily insulin injections (mdi); these advantages include better glycemic control, fewer hypoglycemic events, reduced glycemic variability1 and improved quality of life2. despite these benefits, most people still choose mdi therapy largely due to the complexity, cost and inconvenience of conventional pump technology. the omnipod is a discreet and easy-to-use system that eliminates many of the issues associated with conventional pumps. improvements include omnipod's lack of tubing; automated, virtually pain-free insertion; and two straightforward parts that communicate wirelessly. by breaking down
Insulet executives and other stock owners filed with the SEC include: